CytoMed Therapeutics Limited (GDTC) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
CytoMed Therapeutics Limited has announced changes to its Board of Directors, with Dr. Lucas Luk and Mr. Wu Tao Thomas resigning for personal reasons, not related to company operations or practices. Dr. Luk will continue as Chief Clinical Officer and join the board of a subsidiary, while Dr. Loh Yuin Han steps in to ensure the audit committee maintains its required number of independent directors.
For further insights into GDTC stock, check out TipRanks’ Stock Analysis page.
